MedTrace Logo

Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease

NCT07659652 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-06-22

No results posted yet for this study

Summary

Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD) are common affecting up to 30% of patients with metastatic breast cancer (MBC). The goal of this research is to understand symptom burden and quality of life trajectories in this population and how treatments guide care management decisions.

Conditions

  • Breast Cancer, Quality of Life
  • Breast Cancer, Metastatic
  • Breast Cancer, Metastatic Breast Cancer
  • Leptomeningeal Metastasis of Breast Cancer
  • Brain Metastases From Breast Cancer

Interventions

OTHER

Health-Related Quality of Life (QOL) questionnaires

Participants can complete questionnaires online, via tablet in clinic, or via paper and pencil in clinic

OTHER

Medical Chart Review

Data will be collected from the participants electronic medical record

Sponsors & Collaborators

Principal Investigators

  • Laura Huppert, MD · University of California, San Francisco

  • Michelle Melisko, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2030-12-31
Completion
2035-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07659652 on ClinicalTrials.gov